Sector ratings Charles River Laboratories International, Inc. Xetra

Stocks

Real-time Estimate Tradegate Other stock markets 08:05:06 10/07/2026 +03			5-day change	1st Jan Change
203.75 ^EUR	-5.61%		-10.60%	-

07-09	Morgan Stanley Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT
07-07	Evercore ISI Adjusts Price Target on Charles River Laboratories International to $260 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LONZA GROUP AG	50.44B		AAA
REVOLUTION MEDICINES, INC.	40.63B	-	B	-	-
IQVIA HOLDINGS INC.	34.88B		AAA
BEONE MEDICINES AG	33.67B		-
CELLTRION, INC.	26.29B		A
ASCENDIS PHARMA A/S	17.11B	-	-	-	-
MEDPACE HOLDINGS, INC.	15.29B		BBB
IONIS PHARMACEUTICALS, INC.	10.62B	-	A	-	-
EUROFINS SCIENTIFIC SE	13.74B		AA
ICON PUBLIC LIMITED COMPANY	12.93B		AAA
ABIVAX	12.08B	-	BBB	-	-
BIO-TECHNE CORPORATION	11.09B		AA
TEMPUS AI, INC.	11.04B		A		-
APOGEE THERAPEUTICS, INC.	10.01B	-	B	-	-
KYMERA THERAPEUTICS, INC.	9.79B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	9.29B	-	B	-	-
ALKERMES PLC	8.96B		A
PROTAGONIST THERAPEUTICS, INC.	8.85B		BB		-
IMMUNOVANT, INC.	8.44B	-	BB	-	-
Average	18.17B		A
Weighted average by Cap.			A